Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-26

Clinical Trial Update: Capsaicin Patch 8 % for the Treatment of Persistent Pain After Inguinal Herniotomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the capsaicin 8% patch for persistent pain after inguinal herniotomy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin Patch 8% (Qutenza) (capsaicin topical patch 8%)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Persistent Pain After Inguinal Herniotomy | Phase 3 | Status: TERMINATED